NASDAQ:BOLT

Bolt Biotherapeutics . Stock Predictions

Healthcare > Biotechnology

Buy BOLT

*Your capital is at risk

$4.63

-0.480 (-9.39%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

BOLT Prediction Chart

BOLT Predictions History

Latest community submissions for BOLT.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
paramiparami	Aug 15, 2025	Bearish	$5.15	V	—	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BOLT with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT BOLT BIOTHERAPEUTICS, INC.

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for col...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	18.86%	May 06
GLBE $31.61	5.35%	May 05
SAP $172.39	10.69%	May 05
W WCLD $27.34	27.18%	Apr 29
ADBE $243.57	7.61%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by